Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2500107800Phase 2Completed
Phase 2, randomised, double-blind trial in acute kidney failure (AKF) comparing RN-0001 with Placebo (2 arms). Primary endpoint: Serum creatinine (SCr). Started Aug 2025; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2500107800.